Current PSA level-Less than 1 or undetectable Posts on Medivizor
Navigation Menu

Current PSA level-Less than 1 or undetectable Posts on Medivizor

Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy

Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy

Posted by on Aug 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the use of testosterone replacement therapy (TRT) in men who had definitive treatment for prostate cancer. The authors concluded that TRT was not associated with a higher risk of recurrence in these patients. Some background Prostate cancer (PCa) is commonly fueled by the sex hormone testosterone....

Read More

Low-risk prostate cancer: Predictors of disease progression during active surveillance

Posted by on Apr 2, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined predictors of disease progression in low-risk prostate cancer during active surveillance. Researchers concluded that certain blood markers, biopsy results, and ethnicity could help predict which patients were more likely to experience disease progression.  Some background Active surveillance of prostate...

Read More

Risk factors for disease reclassification in prostate cancer patients on active surveillance

Risk factors for disease reclassification  in prostate cancer patients on active surveillance

Posted by on Jul 16, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined the risk factors that led to disease reclassification (change in grade/status of the disease) in prostate cancer patients under active surveillance. Some background Active surveillance is common in early-stage prostate cancer management. It involves active monitoring of patients for any changes in symptoms or...

Read More

African Americans experience higher rates of reclassification during active surveillance

African Americans experience higher rates of reclassification during active surveillance

Posted by on Jan 12, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether African Americans underwent more frequent reclassifications than Caucasians on active surveillance. Some background Active surveillance involves close observation of the cancer to detect any signs of cancer progression rather than immediate treatment. This is typically carried out in...

Read More

How important is electronic tumor tracking?

How important is electronic tumor tracking?

Posted by on Nov 25, 2014 in Prostate cancer | 0 comments

In a nutshell This report discusses using a device to track tumor sites in follow-up biopsies in prostate cancer.  Some background Biopsies (the removal of tissue from the body and examination to establish the presence of cancer) are a very important part of active surveillance (patient monitoring instead of treatment) in early prostate...

Read More

Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy

Posted by on Aug 22, 2014 in Prostate cancer | 0 comments

In a nutshell This phase III trial is studying prostate radiation therapy to see how well it works compared with short-term androgen deprivation therapy given together with pelvic lymph node radiation therapy with or without prostate radiation therapy in treating patients with a rising prostate specific antien (PSA) after prostatectomy (surgery...

Read More

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Posted by on Jan 18, 2014 in Prostate cancer | 0 comments

In a nutshell This study evaluated the use of multi-parametric magnetic resonance imagining (MRI) in the selection of prostate cancer patients for active surveillance. Some background Active surveillance was introduced as a therapeutic strategy to avoid overtreatment of cancer patients with a relatively non-threatening disease. In active...

Read More